Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

Multidrug-resistant and extensively drug-resistant tuberculosis (TB) are associated with worse treatment outcomes for patients, including higher mortality, than for drug-sensitive tuberculosis. Delamanid (OPC-67683) is a novel anti-TB medication with demonstrated activity against multidrug-resistant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Skripconoka, Vija, Danilovits, Manfred, Pehme, Lea, Tomson, Tarmo, Skenders, Girts, Kummik, Tiina, Cirule, Andra, Leimane, Vaira, Kurve, Anu, Levina, Klavdia, Geiter, Lawrence J., Manissero, Davide, Wells, Charles D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: European Respiratory Society 2013
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669462/
https://ncbi.nlm.nih.gov/pubmed/23018916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/09031936.00125812
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge